Charles Schwab
SWAV

Charles Schwab’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Charles Schwab’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-232,226
Closed -$75.6M – 3713
2024
Q1 		$75.6M Buy
232,226
+5,566
+2% +$1.37M 0.02% 754
2023
Q4 		$43.2M Buy
226,660
+5,660
+3% +$1.07M 0.01% 1088
2023
Q3 		$44M Sell
221,000
-5,524
-2% -$1.31M 0.01% 969
2023
Q2 		$64.7M Sell
226,524
-72,584
-24% -$20.2M 0.02% 711
2023
Q1 		$64.9M Sell
299,108
-477
-0.2% -$92.9K 0.02% 664
2022
Q4 		$61.6M Buy
299,585
+6,733
+2% +$1.7M 0.02% 683
2022
Q3 		$81.4M Buy
292,852
+6,858
+2% +$1.74M 0.03% 515
2022
Q2 		$54.7M Buy
285,994
+1,690
+0.6% +$298K 0.02% 700
2022
Q1 		$59M Sell
284,304
-1,374
-0.5% -$227K 0.02% 763
2021
Q4 		$50.9M Buy
285,678
+18,687
+7% +$3.69M 0.02% 878
2021
Q3 		$55M Buy
266,991
+43,437
+19% +$8.53M 0.02% 798
2021
Q2 		$42.4M Buy
223,554
+14,715
+7% +$2.41M 0.01% 983
2021
Q1 		$27.2M Buy
208,839
+8,576
+4% +$1.03M 0.01% 1272
2020
Q4 		$20.8M Buy
200,263
+3,882
+2% +$336K 0.01% 1380
2020
Q3 		$14.9M Buy
196,381
+97,872
+99% +$5.55M 0.01% 1411
2020
Q2 		$4.67M Buy
98,509
+6,863
+7% +$283K ﹤0.01% 2065
2020
Q1 		$3.04M Buy
91,646
+786
+0.9% +$31.2K ﹤0.01% 2082
2019
Q4 		$3.99M Buy
90,860
+54,185
+148% +$2M ﹤0.01% 2142
2019
Q3 		$1.1M Buy
36,675
+428
+1% +$18.2K ﹤0.01% 2542
2019
Q2 		$2.07M Buy
+36,247
New +$1.76M ﹤0.01% 2361

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Charles Schwab's SWAV Position: Q2 2024 in Review

Charles Schwab sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 232,226 shares — an estimated $75.6M sold.

Charles Schwab first reported a position in SWAV in Q2 2019 and held it in 20 quarters. The position peaked at $81.4M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Charles Schwab reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab sold 232,226 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $75.6M.
  • Charles Schwab first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
  • Charles Schwab's Shockwave Medical, Inc. Common Stock position peaked at $81.4M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.